HENRY KAY
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
DIRECTOR
EILEEN F. BOSTWICK,
DAVID C. DLESK,
DAVID DONABEDIAN,
DAVID H DONABEDIAN,
JOHN EDWARDS,
JONATHAN FLEMING,
BARBARA S FOX,
BARBARA S. FOX,
NADA JAIN,
CHRISTOPHER KIRITSY,
ROBERT MANNING,
DAVID POORVIN
DIRECTOR
JAMES BARTLETT,
JENNIFER J. DAVAGIAN,
JOHN DAVAGIAN,
JOHN S. DAVAGIAN,
JOHN S. DAVAGIAN II,
MARK C. ENSIGN,
MARC KELLER,
ERNEST H. POMERANTZ,
DAVID SHEPARD,
DAVID SHEPHERD,
RICHARD WARBURG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2025-09-25
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2025-04-25
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2024-09-04
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2024-09-04
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
2024-04-16
D
OTHER HEALTH CARE
NOT APPLICABLE
Equity
2023-06-05
D/A
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2018-07-11
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2018-09-12
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2017-09-18
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2017-08-29
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2017-02-10
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-08-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-08-30
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-09-01
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-07-27
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-07-28
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-09-02
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-08-11
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-03-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-03-24
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity, Debt
2015-07-06
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2015-05-28
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2015-04-20
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2014-04-22
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2013-12-11
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-11-01
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-07-10
D/A
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2012-12-14
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2013-03-21
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Equity
2012-12-14
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2011-05-16
D
OTHER HEALTH CARE
DECLINE TO DISCLOSE
Debt
2010-05-28
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Equity
2010-03-10
D
OTHER TECHNOLOGY
DECLINE TO DISCLOSE
Debt
2009-07-24
D
PHARMACEUTICALS
DECLINE TO DISCLOSE
Debt
2009-07-17